Livderm

Chronic skin diseases such as acne, psoriasis, atopic dermatitis, and alopecia areata can significantly impact quality of life, self-esteem, and emotional well-being.

Taking a more holistic approach to care–including recognizing psychological burden and supporting patients beyond the skin–remains an important part of clinical practice.

This Mental Health Awareness Month, let's continue prioritizing compassionate, patient-centered care that addresses both physical and emotional health.

🔬 The treatment landscape for moderate-to-severe atopic dermatitis (AD) is evolving. While traditional biologics have paved the way, the clinical focus is now shifting toward the OX40/OX40L pathway.

💡 Join board-certified dermatologists Christopher G. Bunick, MD, PhD, and Emma Guttman-Yassky, MD, PhD, for an interactive deep dive into the next generation of T cell-mediated therapies.

📚 Enroll in our accredited activity: "Expanding the AD Toolb-OX: A New Pathway for Treating Moderate-to-Severe Disease".

What You'll Learn:
✅ Gaps in AD care
✅ AD pathogenesis
✅ OX40- and OX40L-targeted therapies
✅ The future of AD care

🎓 Earn 1.00 CME Credit

🔗 Start activity now: https://go.livderm.org/4d7Mgz5